|
WO2013185052A1
(en)
|
2012-06-08 |
2013-12-12 |
Aduro Biotech |
Compostions and methods for cancer immunotherapy
|
|
WO2014093936A1
(en)
|
2012-12-13 |
2014-06-19 |
Aduro Biotech, Inc. |
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
|
|
JP6502267B2
(ja)
|
2013-02-18 |
2019-04-17 |
スプリング バンク ファーマシューティカルズ,インコーポレイテッド |
ワクチンアジュバントおよび治療剤としての短鎖オリゴヌクレオチドの設計
|
|
JP6453855B2
(ja)
|
2013-05-18 |
2019-01-16 |
アドゥロ バイオテック,インク. |
「インターフェロン遺伝子の刺激因子」依存性シグナル伝達を活性化するための組成物及び方法
|
|
EP2996472B1
(en)
|
2013-05-18 |
2019-03-27 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
|
|
JP2016538344A
(ja)
*
|
2013-11-19 |
2016-12-08 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
癌処置としてのstingアゴニストの使用
|
|
KR20230097209A
(ko)
|
2014-03-12 |
2023-06-30 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
Cns의 질환 및 손상을 치료하기 위한 전신적 조절 t 세포 수준 또는 활성의 감소
|
|
EP3152217B1
(en)
|
2014-06-04 |
2018-08-01 |
GlaxoSmithKline Intellectual Property Development Limited |
Cyclic di-nucleotides as modulators of sting
|
|
CH710524A2
(fr)
|
2014-12-18 |
2016-06-30 |
Swatch Group Res & Dev Ltd |
Résonateur d'horlogerie à lames croisées.
|
|
GB201501462D0
(en)
|
2015-01-29 |
2015-03-18 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
KR20170129802A
(ko)
|
2015-03-10 |
2017-11-27 |
아두로 바이오테크, 인코포레이티드 |
"인터페론 유전자의 자극인자"-의존적 신호전달을 활성화하는 조성물 및 방법
|
|
WO2017027645A1
(en)
*
|
2015-08-13 |
2017-02-16 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
|
TW201726700A
(zh)
*
|
2015-10-28 |
2017-08-01 |
艾杜諾生物科技公司 |
用於活化「干擾素基因刺激子」依賴性訊號之組合物及方法
|
|
HK1250032A1
(zh)
|
2015-12-03 |
2018-11-23 |
Glaxosmithkline Intellectual Property Development Limited |
作为sting调节剂的环状嘌呤二核苷酸
|
|
CN106540260A
(zh)
|
2015-12-09 |
2017-03-29 |
聊城市奥润生物医药科技有限公司 |
干扰素基因刺激蛋白(sting)激动剂在抗阿尔兹海默症中的应用
|
|
WO2017106740A1
(en)
*
|
2015-12-16 |
2017-06-22 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"-dependent interferon production
|
|
WO2017123657A1
(en)
|
2016-01-11 |
2017-07-20 |
Gary Glick |
Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
|
|
AU2017207757B2
(en)
|
2016-01-11 |
2021-05-27 |
Innate Tumor Immunity, Inc. |
Cyclic dinucleotides for treating conditions associated with STING activity such as cancer
|
|
JP2019511483A
(ja)
|
2016-03-02 |
2019-04-25 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
免疫療法のためのsting活性化ナノワクチン
|
|
CA3017524A1
(en)
|
2016-03-18 |
2017-09-21 |
Immune Sensor, Llc |
Cyclic di-nucleotide compounds and methods of use
|
|
EP3448393A1
(en)
*
|
2016-04-25 |
2019-03-06 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
|
WO2018009466A1
(en)
|
2016-07-05 |
2018-01-11 |
Aduro Biotech, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
|
WO2018045204A1
(en)
|
2016-08-31 |
2018-03-08 |
Ifm Therapeutics, Inc |
Cyclic dinucleotide analogs for treating conditions associated with sting (stimulator of interferon genes) activity
|
|
CR20190168A
(es)
|
2016-10-04 |
2019-05-17 |
Merck Sharp & Dohme |
Compuestos de benzo[b]tiofeno como agonistas de sting
|
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
|
AU2017378782A1
(en)
|
2016-12-20 |
2019-07-04 |
Merck Sharp & Dohme Corp. |
Combinations of PD-1 antagonists and cyclic dinucleotide sting agonists for cancer treatment
|
|
US20200113924A1
(en)
|
2016-12-20 |
2020-04-16 |
Merck Sharp & Dohme Corp. |
Cyclic dinucleotide sting agonists for cancer treatment
|
|
CA3053568A1
(en)
|
2017-02-21 |
2018-08-30 |
Board Of Regents, The University Of Texas System |
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
|
|
UY37695A
(es)
|
2017-04-28 |
2018-11-30 |
Novartis Ag |
Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
|
|
EP3621624B1
(en)
|
2017-05-12 |
2023-08-30 |
Merck Sharp & Dohme LLC |
Cyclic di-nucleotide compounds as sting agonists
|
|
WO2018231752A1
(en)
|
2017-06-12 |
2018-12-20 |
University Of Miami |
Sting-dependent activators for treatment of disease
|
|
WO2018234807A1
(en)
|
2017-06-22 |
2018-12-27 |
Curadev Pharma Limited |
Heterocyclic small molecule modulators of human sting
|
|
PE20200696A1
(es)
|
2017-06-22 |
2020-06-16 |
Curadev Pharma Ltd |
Moduladores de moleculas pequenas de sting humana
|
|
US20200138827A1
(en)
|
2017-06-22 |
2020-05-07 |
Curadev Pharma Limited |
Small molecule modulators of human sting
|
|
EP3661498A4
(en)
|
2017-08-04 |
2021-04-21 |
Merck Sharp & Dohme Corp. |
BENZO [B] THIOPHEN STING ANTAGONISTS FOR CANCER TREATMENT
|
|
WO2019027857A1
(en)
|
2017-08-04 |
2019-02-07 |
Merck Sharp & Dohme Corp. |
COMBINATIONS OF PD-1 ANTAGONISTS AND STING BENZO [B] THIOPHENIC AGONISTS FOR THE TREATMENT OF CANCER
|
|
WO2019035901A1
(en)
|
2017-08-15 |
2019-02-21 |
University Of Miami |
COMPOSITIONS AND METHODS FOR STING PROTEIN MODULATION
|
|
EP3675859A4
(en)
|
2017-08-31 |
2021-06-30 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF A DISEASE
|
|
WO2019067468A1
(en)
|
2017-09-26 |
2019-04-04 |
La Jolla Institute For Allergy And Immunology |
MODULATION OF THE IMMUNE RESPONSE THROUGH THE STING PROTEIN
|
|
MX2020004902A
(es)
|
2017-11-20 |
2020-09-09 |
Silicon Swat Inc |
Derivados del acido oxoacridinilo acetico y metodos de uso.
|
|
WO2019104353A1
(en)
|
2017-11-27 |
2019-05-31 |
Children's Medical Center Corporation |
Stimulator of interferon genes (sting) ligands and uses thereof
|
|
US11685761B2
(en)
|
2017-12-20 |
2023-06-27 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
|
CN111655281A
(zh)
|
2018-01-26 |
2020-09-11 |
加利福尼亚大学董事会 |
用于结核病的含环二核苷酸佐剂的疫苗的鼻内递送
|
|
WO2019161171A1
(en)
|
2018-02-16 |
2019-08-22 |
Sperovie Biosciences, Inc. |
Nanoparticle formulations of sting agonists
|
|
WO2019165032A1
(en)
|
2018-02-21 |
2019-08-29 |
The Scripps Research Institute |
Agonists of stimulator of interferon genes sting
|
|
CA3097850A1
(en)
|
2018-03-26 |
2019-10-03 |
University Of Miami |
Recombinant viral vector and uses thereof
|
|
US10793557B2
(en)
|
2018-04-03 |
2020-10-06 |
Merck Sharp & Dohme Corp. |
Sting agonist compounds
|
|
EP3774765A4
(en)
|
2018-04-03 |
2021-12-29 |
Merck Sharp & Dohme Corp. |
Aza-benzothiophene compounds as sting agonists
|
|
EP3801579A1
(en)
|
2018-06-04 |
2021-04-14 |
Aarhus Universitet |
Worm products and methods of use
|
|
EP3807264A1
(en)
|
2018-06-12 |
2021-04-21 |
Ryvu Therapeutics S.A. |
Modulators of stimulator of interferon genes (sting)
|
|
CN108498529A
(zh)
|
2018-06-20 |
2018-09-07 |
福建师范大学 |
用于肿瘤预防治疗的DNA甲基转移酶抑制剂与cGAMP药物组合物
|
|
WO2019243823A1
(en)
|
2018-06-21 |
2019-12-26 |
Curadev Pharma Limited |
Azaheterocyclic small molecule modulators of human sting
|
|
TW202016081A
(zh)
|
2018-06-21 |
2020-05-01 |
英商克拉德夫製藥有限公司 |
人類sting之小分子調節劑、結合物及治療應用
|
|
JP7566731B2
(ja)
|
2018-07-03 |
2024-10-15 |
アイエフエム デュー インコーポレイテッド |
Sting活性に関連する状態を治療するための化合物および組成物
|
|
WO2020010451A1
(en)
|
2018-07-10 |
2020-01-16 |
Trillium Therapeutics Inc. |
Heteroaromatic-fused imidazolyl amides, compositions and uses thereof as sting agonists
|
|
AU2019311031A1
(en)
|
2018-07-23 |
2021-03-18 |
Fosun Orinove Pharmatech, Inc. |
IRE1α inhibitor in combination with cancer therapeutic agent for cancer treatment
|